Institute for Systems Biology focuses on some of the most pressing issues in human health, including cancer and brain health. ISB President and Professor James Heath, PhD, is a PICI investigator who bridges cutting-edge technology and immune system biology. He builds new technologies to investigate how individual patients’ immune systems respond to therapeutic interventions including vaccines, checkpoint blockade and CAR-T cell therapy. He collaborates with PICI in high-need areas, pushing progress in glioblastoma and brain tumor research. James Heath, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement, Our Impact, Research Update 5 Years of Transforming Cancer Immunotherapy Research Announcement, Our Impact, Research Update New CAR-T Approach Shows Promise for Lymphoma Patients Press Release Funding the Future of Cancer Research Cancer Research Heroes Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas Press Release Ute Dugan Joins PICI as Senior VP of Clinical Research Partner Highlight Seeking Solutions for Deadly Brain Tumors: ACGT Our Impact, Research Update Tackling Pancreatic Cancer with a Triple Threat
Cancer Research Heroes Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas